Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-03

Clinical Trial Update: Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating luteal phase support with daily GnRH agonist versus progesterone/estradiol in IVF/ICSI cycles with GnRH agonist trigger; status unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonadotropin-releasing hormone agonist (GnRH agonist) daily luteal support (gonadotropin-releasing hormone agonist)
  • Progesterone/estradiol luteal support (progesterone/estradiol)

Snippet

Sponsor: Kuban State Medical University | Conditions: Infertility | Phase 2 | Status: UNKNOWN